CLL and ASCT Failure

CLL and ASCT Failure

The outcomes of 72 patients (52 with chronic lymphocytic leukaemia (CLL) and 20 with Richter’s transformation [RT]) who had undergone…

More...
Use of DNA as a Biomarker

Use of DNA as a Biomarker

This study aimed to assess whether circulating tumour DNA could be detected in the serum of patients with diffuse large…

More...
Ibrutinib Use in WM

Ibrutinib Use in WM

A prospective study was undertaken in 63 patients with symptomatic Waldenström’s Macroglobulinaemia (WM) who had received at least one previous…

More...
Radiation and HL

Radiation and HL

A case-control study was undertaken at the Netherlands Cancer Institute to assess the dose-response relationship between radiation therapy and the…

More...
Frontpage Slideshow | Copyright © 2006-2014 JoomlaWorks Ltd.

Healthcare Matters

  • 1
  • 2
Prev Next

A Peek at the Leukaemia Foundation of Au …

A Peek at the Leukaemia Foundation of Australia

One of the main goals of the Leukaemia Foundation of Australia (LFA) is to ensure people diagnosed with a blood cancer are aware of the support that is available to them.

“To achieve this, we set ourselves a goal of having face-to-face contact with 50% of all newly diagnosed patients across Australia which we did for the first time in 2014,” said Anthony Steele, Head of Blood Cancer Support at the LFA.

Read more

Highlights from the 2015 T-Cell Lymphoma …

Highlights from the 2015 T-Cell Lymphoma Forum

The seventh annual T-Cell Lymphoma Forum was held in San Francisco at the end of January. It provided a forum for researchers, scientists and clinicians from around the world to come together to provide updates and latest findings in molecular pathogenesis as well as potential treatment options for patients with peripheral T-cell lymphomas (PTCLs), cutaneous T-cell lymphomas (CTCLs) and natural killer (NK) T-cell lymphomas (TCLs).

Read more

 KYN4   facebook2 twitter2 youtube1

Latest Lymphoma News

  • Predicting Outcomes for MF/SS

    Multiple prognostic variables were prospectively evaluated for 168 patients with advanced stage mycosis fungoides (MF) and Sézary syndrome (SS).
    Read more ...

  • Farming and Risk of NHL

    The Agricultural Health Study, undertaken in two states in the USA, evaluated farm characteristics, allergic symptoms and conditions among farmers (n = 82,370) to determine the risk of developing non-Hodgkin lymphoma (NHL) neoplasms.


    Read more ...

What's Happening Around the World

  • A Peek at OLHB Kraujas (Lithuania)

    The impetus for the founding of OHLB Kraujas (Oncohaematological Patients’ Association of Blood) in 2002 was the need to improve the availability of new therapies in Lithuania.

    Read more ...  
  • A Peek at Group Nexus Japan

    Until 2001, patients with lymphoma did not have their own patient support group in Japan. That changed when the mother of one of the founders of Group Nexus Japan was receiving treatment for lymphoma

    Read more ...  

Research

  • Bortezomib Use in MCL

    In this phase III trial, 487 patients with newly diagnosed mantle cell lymphoma who were not eligible or not considered for stem-cell transplantation were randomised to receive R-CHOP or VR-CAP.

    Read more ...  
  • MCL and miR-18b

    Analysis of diagnostic mantle cell lymphoma (MCL) samples from the Nordic MCL2 (n= 74) and Nordic MCL3 (n = 94) clinical trials showed that overexpression of miR-18b identified patients with a poor prognosis.

    Read more ...  

 
The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or require more detailed information on the best course of treatment for you.

Global Database Search

IN THE NODE

Updates